Amoy Diagnostics Gets China OK for Cancer MDx Tests

China's State Food and Drug Administration granted approval for its EGFR and BRAF tests for clinical use.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories